Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Roche Holding Ltd.
Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics

Roche Holding AG operates as a research healthcare company.

It operates through the following segments: Diagnostics and Pharmaceuticals.

The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience.

The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process.

The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Number of employees : 94 052 persons.
Sales per Businesses
20152016Delta
CHF (in Million)%CHF (in Million)%
Pharmaceuticals39,45081.9%41,04781.2% +4.05%
Diagnostics10,95322.8%11,58922.9% +5.81%
Sales per Regions
20152016Delta
CHF (in Million)%CHF (in Million)%
United States22,18846.1%22,95945.4% +3.47%
Rest of Europe10,05020.9%10,26720.3% +2.16%
Rest of Asia6,01512.5%6,47112.8% +7.58%
Japan3,6797.6%4,2438.4% +15.33%
Latin America2,8325.9%2,6815.3% -5.33%
Germany2,7585.7%3,0326% +9.93%
Africa, Australia and Oceania1,3632.8%1,3352.6% -2.05%
Rest of North America856.001.8%852.001.7% -0.47%
Switzerland662.001.4%796.001.6% +20.24%
Managers
NameAgeSinceTitle
Severin Schwan502008Chief Executive Officer & Executive Director
Christoph Franz572011Chairman
Alan Hippe, PhD502011Chief Financial & Information Technology Officer
John Irving Bell, MD652001Non-Executive Director
Andreas Oeri, MD681996Independent Non-Executive Director
Paul Bulcke632011Non-Executive Director
Peter R. Voser582011Non-Executive Director
André S. Hoffmann, MBA581996Vice Chairman
Bernard J. Poussot652015Non-Executive Director
Richard P. Lifton MD, PhD592015Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 702,562,700 693,297,592 98.7% 9,265,108 1.3% 83.5%
Share B 1 160,000,000 26,557,237 16.6% 0 0.0%
Shareholders
NameEquities%
The Vanguard Group, Inc. 17,597,983 2.50%
Norges Bank Investment Management 17,167,261 2.44%
UBS AG (Investment Management) 11,212,942 1.60%
PRIMECAP Management Co. 9,013,749 1.28%
Wellington Management Co. LLP 8,209,085 1.17%
BlackRock Fund Advisors 8,181,108 1.16%
Credit Suisse Asset Management (Schweiz) AG 6,340,875 0.90%
Massachusetts Financial Services Co. 5,847,505 0.83%
Alecta Pension Insurance Mutual 5,843,000 0.83%
Dodge & Cox 5,734,030 0.82%
Holdings
NameEquities%Valuation
Chugai Pharmaceutical Co Ltd (4519) 335,223,00059.9%13,907,443,532 USD
Foundation Medicine Inc (FMI) 21,019,11158.4%844,968,262 USD
Senseonics Holdings Inc (SENS) 28,345,27621.0%90,421,430 USD
Curetis (CURE) 966,4896.22%5,690,069 USD
Company contact information
Roche Holding AG
Grenzacherstrasse 124
Basel, Basel-Stadt (Basle Town) 4070

Phone : +41.61.688.11.11
Fax : +41.61.691.93.91
Web : www.roche.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.0.77%207 116
JOHNSON & JOHNSON23.60%382 202
NOVARTIS13.97%226 404
PFIZER12.13%216 886
MERCK AND COMPANY8.51%174 223
AMGEN25.14%133 501
SANOFI8.99%124 704
BAYER18.99%114 930
BRISTOL-MYERS SQUIBB COMPANY10.23%105 644
NOVO NORDISK A/S25.13%99 069
GLAXOSMITHKLINE-2.46%98 802
ABBOTT LABORATORIES46.63%97 853
ELI LILLY AND COMPANY18.60%96 039
CELGENE CORPORATION4.82%94 923
ASTRAZENECA16.33%85 977
ALLERGAN PLC-10.35%62 943
TAKEDA PHARMACEUTICAL CO LTD30.92%44 061
SHIRE-21.49%43 958
ASTELLAS PHARMA INC-6.52%27 777
JIANGSU HENGRUI MEDICINE CO LTD42.81%27 656
CHUGAI PHARMACEUTICAL CO LTD60.36%26 174
Connections : Roche Holding Ltd.
Peace Parks Foundation
Credit Suisse (Schweiz) AG
Credit Suisse AG
Fondation Pro Valat
European Round Table of Industrialists
International Business Leaders Advisory Council
Givaudan Foundation
International Federation of Pharmaceutical Manufacturers A
Glyndebourne Productions Ltd.
International Committee of the Red Cross
Fondation Prince Albert II of Monaco
Roche Holdings, Inc.
New York Genome Center
Swiss-American Chamber of Commerce
Zurich Insurance Co. Ltd.
Stadler Rail AG
Fondation Hoffmann
Fondation MAVA
Ernst Göhner Foundation
Inovalon, Inc.
Zurich Insurance Group Ltd.
Lucerne Festival
Fondation les Corbillettes
Voith GmbH
Paul Sacher Stiftung
The Oxford Health Alliance
Systemiq Ltd.
GMEC Management Co. Ltd.
The Rockefeller University
Catalyst, Inc.
Office for Strategic Co-ordination of Health Research
Oxford Sciences Innovation Plc
St. Gallen Foundation for International Studies
Immunocore Ltd.
Temasek Holdings (Pte) Ltd.
Oxagen Ltd.
Peter G. Peterson Institute for International Economics
Oxford University Hospitals NHS Trust
Fondation pour l’art musical, lyrique et chorégraphique
The Gray Laboratory Cancer Research Trust
Fondation Internationale du Banc d'Arguin
Rhodes Trust
Institute For Strategic Dialogue
The Ewelme Almshouse Charity
Genomics England Ltd.
Amazentis SA
Oxford Centre for Diabetes Endocrinology & Metabolism
The Jenner Institute
WWF International
Fondation Tour du Valat
Cereal Partners Worldwide SA
Fondation Dr Henri Dubois-Ferrière Dinu Lipatti
University of Oxford
Fondation Auxiliaire du Conservatoire botanique de la Ville de
Max Planck Florida Institute for Neuroscience
Weidenfeld Hoffmann Trust
Fort Dodge Animal Health, Inc.
Fondation Jan Michalski Pour L'écriture Et La Littérature
Nestlé Health Science SA
Tate Gallery Foundation, Inc.
Nestlé Skin Health SA
Eisenhower Fellowships, Inc.
L'Oréal USA, Inc.
ESCP Europe Campus Paris
The Rockefeller Archive Center
IMD Scholarship Foundation
Yale School of Medicine
© 2017 People , Fundamentals and Ownership